Hikma Pharmaceuticals PLC (HIK.L)

1.854,00 +41,00 (+2,26%) Al cierre: 05:24PM BST

Hikma Pharmaceuticals PLC

1 New Burlington Place
London W1S 2HR
United Kingdom
44 20 7399 2760
https://www.hikma.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 9100

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Engineer Said Samih Taleb Darwazah	Executive Chairman	2,25M	N/A	1957
Mr. Riad Ali Mishlawi	CEO & Director	885,75k	N/A	1964
Mr. Mazen Samih Taleb Darwazah	Executive Vice Chairman & President of MENA	1,85M	N/A	1958
Mr. Khalid Waleed Hosny Al Nabilsi	Chief Financial Officer	N/A	N/A	1972
Patricia Bousfield	Chief Information Officer	N/A	N/A	N/A
Mr. Guy Featherstone	Associate Director of Investor Relations	N/A	N/A	N/A
Mr. Samuel Park	General Counsel	N/A	N/A	N/A
Mr. Bassam Wael Rushdi Kanaan CFA, CPA	Executive Vice President of Corporate Development and M&A	N/A	N/A	1965
Mr. Hussein Omar Arkhagha	Chief People Officer	N/A	N/A	N/A
Ms. Susan Ringdal	Executive Vice President of Strategic Planning & Global Affairs	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en GBp.

Descripción

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Gobierno corporativo

El ISS Governance QualityScore de Hikma Pharmaceuticals PLC, a día 1 de abril de 2024, es 7. Las puntuaciones base son Auditoría: 6; Tablero: 9; Derechos de los accionistas: 7; Compensación: 3.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.